Pliant Therapeutics Appoints Minnie Kuo as Chief Development Officer

SOUTH SAN FRANCISCO, Calif., Sept. 15, 2023 -- Pliant Therapeutics, Inc. , a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of...

Related Keywords

University Of San Francisco ,California ,United States ,San Diego ,Roche Genentech ,Bernard Coulie ,Christopher Keenan ,Twitter ,Development Officer ,European Medicines Agency ,Gilead Sciences ,Nasdaq ,Company On ,Pliant Therapeutics Inc ,Nektar Therapeutics ,Drug Administration ,University Of California ,Corporate Communications ,Clinical Development Operations ,Youtube ,Linkedin ,Facebook ,Minnie Kuo ,Chief Development ,Chief Executive Officer ,Vir Biotechnology ,Senior Vice President ,Clinical Development ,Chief Medical Officer ,Pliant Therapeutics ,Fast Track Designation ,Orphan Drug Designation ,Grant Under Nasdaq Listing Rule ,Inducement Grant ,Incentive Plan ,Nasdaq Listing Rule ,Media Contact ,Investor Relations ,Markets ,